Target intelligence / Profile preview

Staphylococcus aureus 70S ribosome (70S ribosome)

Target
70S ribosome
Molecular classification
Ribonucleoprotein complex, Enzyme, Ribozyme
01

Overview

The Staphylococcus aureus ribosome is a complex 70S ribonucleoprotein machinery essential for the translation of genetic information into functional proteins within the cell (Wilson, 2014, Nat Rev Microbiol). It is composed of two major subunits: the small 30S subunit, which facilitates the decoding of messenger RNA (mRNA), and the large 50S subunit, which catalyzes peptide bond formation at the peptidyl transferase center (PTC). As a critical component of bacterial survival and virulence, the ribosome is a primary target for several major classes of antibiotics, including macrolides, tetracyclines, and oxazolidinones (Foster, 2017, Frontiers in Microbiology). These therapeutic agents typically bind to highly conserved regions of the ribosomal RNA (rRNA) to arrest protein synthesis, leading to bacteriostatic or bactericidal effects. However, S. aureus has developed sophisticated resistance mechanisms, such as the enzymatic methylation of rRNA by Erm methyltransferases or point mutations in the 23S rRNA, which hinder drug binding and complicate the treatment of multidrug-resistant infections like MRSA (Munita & Arias, 2016, Microbiol Spectr).

Other names
Bacterial ribosomeS. aureus ribosome70S translation complexStaphylococcal ribosome
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to specific sites on the 30S or 50S ribosomal subunits, which interferes with mRNA decoding, tRNA binding, or the peptidyl transferase reaction.

03

Biological functions

Protein synthesisTranslationPeptide bond formationmRNA decoding
04

Disease associations

Staphylococcal infectionSepsisPneumoniaSkin and soft tissue infectionInfective endocarditisOsteomyelitis
05

Safety considerations

Antibiotic resistance (e.g., MRSA, VRSA)Mitochondrial toxicity (due to structural similarity between bacterial and mitochondrial ribosomes)Myelosuppression (associated with long-term oxazolidinone use)Gastrointestinal dysbiosisSerotonin syndrome (potential interaction with oxazolidinones)
06

Interacting drugs

Linezolid

12 more in the full profile.

07

Biomarkers

16S rRNA sequence23S rRNA mutations (e.g., G2576T)erm gene (erythromycin ribosome methylation)cfr gene (chloramphenicol-florfenicol resistance)

Beyond the preview

Go deeper on Staphylococcus aureus 70S ribosome (70S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus 70S ribosome (70S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call